Chengdu Easton Biopharmaceuticals Co Ltd (688513) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.021x

Based on the latest financial reports, Chengdu Easton Biopharmaceuticals Co Ltd (688513) has a cash flow conversion efficiency ratio of 0.021x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥61.35 Million ≈ $8.98 Million USD) by net assets (CN¥2.87 Billion ≈ $419.38 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Chengdu Easton Biopharmaceuticals Co Ltd market capitalisation for the company's overall valuation and market capitalisation.

Chengdu Easton Biopharmaceuticals Co Ltd - Cash Flow Conversion Efficiency Trend (2013–2025)

This chart illustrates how Chengdu Easton Biopharmaceuticals Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Chengdu Easton Biopharmaceuticals Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Chengdu Easton Biopharmaceuticals Co Ltd ranked by their cash flow conversion efficiency. Explore cash flow quality index of Chengdu Easton Biopharmaceuticals Co Ltd to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
SHANG.FOS.PHARM.GR.H YC 1 F:08HH	N/A
ACV Auctions Inc. NASDAQ:ACVA	0.024x
Lucky Harvest SHE:002965	0.010x
ROMANDE ENERGIE SA SW:REHN	0.072x
Zhejiang Merit Interactive Network Technology Co Ltd Class A SHE:300766	-0.009x
Sonic Automotive Inc NYSE:SAH	0.036x
Hisense Home Appliances Group Co. Ltd F:GKE	0.212x
The South Indian Bank Limited NSE:SOUTHBANK	-0.457x

Annual Cash Flow Conversion Efficiency for Chengdu Easton Biopharmaceuticals Co Ltd (2013–2025)

The table below shows the annual cash flow conversion efficiency of Chengdu Easton Biopharmaceuticals Co Ltd from 2013 to 2025. View Chengdu Easton Biopharmaceuticals Co Ltd share price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥6.66 Billion ≈ $975.13 Million	CN¥264.94 Million ≈ $38.77 Million	0.040x	-59.25%
2024-12-31	CN¥2.70 Billion ≈ $394.79 Million	CN¥263.24 Million ≈ $38.52 Million	0.098x	-7.71%
2023-12-31	CN¥2.60 Billion ≈ $380.96 Million	CN¥275.25 Million ≈ $40.28 Million	0.106x	+70.09%
2022-12-31	CN¥2.44 Billion ≈ $357.70 Million	CN¥151.94 Million ≈ $22.23 Million	0.062x	-3.49%
2021-12-31	CN¥2.29 Billion ≈ $335.34 Million	CN¥147.60 Million ≈ $21.60 Million	0.064x	-13.79%
2020-12-31	CN¥2.10 Billion ≈ $306.60 Million	CN¥156.52 Million ≈ $22.90 Million	0.075x	-63.26%
2019-12-31	CN¥697.44 Million ≈ $102.06 Million	CN¥141.83 Million ≈ $20.75 Million	0.203x	-29.02%
2018-12-31	CN¥582.19 Million ≈ $85.19 Million	CN¥166.79 Million ≈ $24.41 Million	0.286x	+48.85%
2017-12-31	CN¥445.28 Million ≈ $65.16 Million	CN¥85.70 Million ≈ $12.54 Million	0.192x	-29.27%
2016-12-31	CN¥389.79 Million ≈ $57.04 Million	CN¥106.06 Million ≈ $15.52 Million	0.272x	+44.32%
2015-12-31	CN¥268.21 Million ≈ $39.25 Million	CN¥50.57 Million ≈ $7.40 Million	0.189x	-17.97%
2014-12-31	CN¥203.25 Million ≈ $29.74 Million	CN¥46.71 Million ≈ $6.84 Million	0.230x	+37.82%
2013-12-31	CN¥168.62 Million ≈ $24.67 Million	CN¥28.12 Million ≈ $4.11 Million	0.167x	--

About Chengdu Easton Biopharmaceuticals Co Ltd

SHG:688513 China Biotechnology

Market Cap

$1.29 Billion

CN¥8.82 Billion CNY

Market Cap Rank

#7884 Global

#1800 in China

Share Price

CN¥49.98

Change (1 day)

+2.97%

52-Week Range

CN¥41.53 - CN¥79.60

All Time High

CN¥79.60